Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Dec;42(10):728-35.
doi: 10.1002/lsm.20984.

Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial

Affiliations
Clinical Trial

Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial

Elma D Baron et al. Lasers Surg Med. 2010 Dec.

Abstract

Background: Photodynamic therapy (PDT) is a non-invasive treatment for non-melanoma skin cancer. However, PDT systems currently used clinically have limitations such as pain and superficial tissue penetration. The silicon phthalocyanine Pc 4 is a second-generation photosensitizer with peak absorption in the far red at 675 nm.

Objective: To assess the safety and tolerability of topically applied Pc 4 followed by red light (Pc 4-PDT) in treating cutaneous neoplasms.

Study design/materials and methods: Forty three adults with a diagnosis of neoplasms including actinic keratoses, Bowen's disease, squamous cell carcinoma, basal cell carcinoma, or mycosis fungoides were treated with a single administration of Pc 4-PDT and followed for 14 days. The study utilized a light and Pc 4 dose escalation design in sequential groups of three subjects each.

Results: Pc 4-PDT was well tolerated with no significant local toxicity or increased photosensitivity. It has promising biologic effects, particularly in mycosis fungoides where 14 of 35 subjects demonstrated a clinical response, which correlates with Pc 4-PDT-induced apoptosis, as measured by increased active caspase-3 in the treated skin lesions.

Conclusions: Pc 4-PDT is a safe and tolerable treatment modality that effectively triggers apoptosis in cutaneous neoplasms such as mycosis fungoides.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chemical structure of Pc 4 and excitation and emission spectra.
Fig. 2
Fig. 2
Box plot of off-site MED at baseline and 24 hours after Pc 4-PDT. White bar = median, red box = 25th–75th percentiles, bars = entire range, whisker line = outliers.
Fig. 3
Fig. 3
Percent area of tissue section that stained positive for active caspase 3 among responders and nonresponders to Pc 4–PDT.
Fig. 4
Fig. 4
Left (untreated) Numerous a typical lymphocytes with halos throughout a spongiotic epidermis and prominently along the basal layer. Sparse, superficial perivascular mononuclear cell infiltrate in the dermis. Right (Pc 4–PDT treated) Basket weave ortho keratosis overlies an epidermis with rete. The papillary dermis shows fibroplasia with increased vessels and a perivascular mononuclear cell infiltrate suggesing a resolving inflammatory process.

Similar articles

Cited by

References

    1. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Roelandts R, Wennberg AM, Morton CA. Guidelines on the use of photodynamic therapy for nonmelanoma skin caner: An international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56:125–143. - PubMed
    1. Morton C, Campbell S, Gupta G, Keohane S, Lear J, Zaki I, Walton S, Kerrouche N, Thomas G, Soto P, AKtion Investigators Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryo-therapy in subjects with actinic keratoses: A multicentre, randomized controlled study. Br J Dermatol. 2006;1:66–71. - PubMed
    1. Steinbauer JM, Schremi S, Babilas P, Zeman F, Karrer S, Landthaler M, Szeimies RM. Topical photodynamic therapy with porphyrin precursors-assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci. 2009;8:1111–1116. - PubMed
    1. Grapengiesser S, Gudmundsson F, Larkö O, Ericson M, Rosén A, Wennberg A-M. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493–497. - PubMed
    1. He J, Larkin HE, Li Y, Rihter BS, Zaidi S, Rodgers M, Mukhtar H, Kenney ME, Oleinick NL. The synthesis, photophysical and photobiological properties and in vitro structure—Activity relationships of a set of silicon phthalocyanine PDT photosensitizers. Photochem Photobiol. 1997;65:581–586. - PubMed

Publication types